Weight loss: ReShape Medical forms up $16M | Wall Street Beat

MassDevice.com Wall Street Beat

ReShape Medical reeled in $15.8 million of a hoped-for $21.5 million funding round from a group of 7 unnamed investors, according to a regulatory filing.

The San Clemente, Calif.-based medical device company is developing a non-surgical weight loss device, the ReShape Duo, to treat obese patients. The device is a dual balloon designed to take up space in the stomach to reduce its capacity for food. 

In June, ReShape landed $1.5 million in a debt round, according to a separate filing.

ReShape launched a Phase I U.S. investigational device exemption trial of the Duo device in March 2010, announcing in June 2011 that 21 patients in the 30-subject study "achieved an average of 32% excess weight loss and maintained much of this weight loss 6 months after the device was removed."

 Medtronic lands DoD deal
Medtronic (NYSE:MDT) won a fixed-price, $63 million contract for radiology imaging systems from the U.S. Defense Dept.
Read more

 Baxter offers buyouts to 16k pensioners
Baxter (NYSE:BAX) offered lump-sum payments to 16,000 vested former employees, a spokeswoman told Pensions & Investments magazine, for any vested worker who left before July 1, 2011. BAX had $3.67 billion in pension assets and $4.94 billion in liabilities for a funded status of 74.3% as of Dec. 31, 2011, according to the magazine.
Read more

 Varian, Siemens expand partnership
Siemens (NYSE:SI) and Varian Medical (NYSE:VAR) are expanding their radiosurgery collaboration to jointly pursue diagnostic and therapeutics solutions in image-guided radiosurgery and radiotherapy. The medical device companies plan to extend the partnership into North America as of Oct. 26 for "the mutual marketing and representation of products for imaging and treatment in radiation oncology" including "the development of software interfaces between Siemens and Varian treatment systems."

"This partnership will make it possible for us to accelerate innovation and provide more efficient and effective end-to-end imaging and treatment solutions that draw on the strengths of each company," Karla Donohoe, senior director of strategic planning and business integration at Varian, said in prepared remarks.
Read more

 Chinese consortium forms Broncus Medical

Medtronic-backed (NYSE:MDT) LifeTech Scientific (HK:8122) a Chinese venture capital shop and a Hong Kong-based private equity fund formed Broncus Medical, "a global strategic partnership to develop and commercialize innovative medical devices for the diagnosis and treatment of lung cancer."

Last week, Medtronic announced a $66.2 million investment in LifeTech Scientific that brought it a 26% stake in the Chinese company.
Read more

 Analysts’ ups and downs

  • Amgen (NSDQ:AMGN): Deutsche Bank raises upgrades from "hold" to "buy" rating, increases price target from $84 to $108.
  • Dentsply International (NSDQ:XRAY): UBS downgrades to "sell" from "neutral" rating, sets $35 price target.
  • Edwards Lifesciences (NYSE:EW): Citigroup downgrades from "buy" to "neutral" rating, lowers price target from $101 to $95; Credit Suisse lowers price target to $96, cuts estimates, sets "neutral" rating; Goldman Sachs Group reiterates "buy" rating, raises price target from $107 to $109; J.P. Morgan & Co. reiterates "neutral" rating, $87.00 price target; Jefferies & Co. reiterates "buy" rating, lowers price target from $125 to $100; Leerink Swann maintains "outperform" rating, lowers price target from $118-$121 to $100, ups estimates.
  • Intuitive Surgical (NSDQ:ISRG): JPMorgan Chase upgrades from "neutral" to "overweight" rating, raises price target to $625 from $610.
  • Medtronic (NYSE:MDT): Lazard reaffirms "buy" rating, sets $48 price target.
  • Opko (NYSE:OPK): Barrington Research initiates coverage with "outperform" rating, $6 price target.
  • Smith & Nephew (FTSE:SN, NYSE:SNN): Barclays Capital reaffirms “equal weight” rating, $10.64 (£6.65) price target.
  • Syneron Medical Ltd. (NSDQ:ELOS): TheStreet Ratings downgrades from "hold" to "sell" rating.
  • Volcano (NSDQ:VOLC): Leerink Swann reiterates "outperform" rating, $32 price target.

RSS From Medical Design & Outsourcing

  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]
  • MasterControl’s CEO talks EQMS software and new partnerships
    MasterControl offers a quality and compliance software that helps device companies speed time to market and improve their bottom lines. Under Jon’s leadership, the company has blossomed into a market leader and has a unique corporate culture that fosters growth, excellence and quality. In this podcast, MasterControl’s CEO, Jon Beckstrand, will discuss electronic quality management […]
  • BIT Group launches white label IVD solutions
    BIT Group has launched a product line of customizable IVD white label instruments. During recent years, BIT has invested capital and resources developing customizable, ready-to-use IVD systems to address a growing demand. “The IVD market is challenging for our clients,” said Marius Balger, CEO at BIT. “OEM’s must adhere to a growing number of evolving IVD […]
  • Toshiba expands line-up of ARM Cortex-M-based microcontrollers
    Toshiba announced that it has enhanced its current “TX Family” of ARM core-based microcontrollers and started to develop three series of microcontrollers, “TXZ0 series,” “TXZ3 series” and “TXZ4 series,” as part of the “TXZTM Family.” The TXZTM Family is a new collection of flash microcontrollers that support low-power consumption and high-speed operation for IoT and M2M […]
  • Parker Hannifin consolidates, layoffs ahead
    Parker Hannifin plans to consolidate a number of internal divisions, close 2 facilities and expand its Mexican operations, according to an internally distributed letter from Andy Ross, Parker’s engineered materials group president. The company has confirmed the letter was authentic, but has not disclosed how many employees will be affected by the new plans or […]
  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]

Leave a Reply